{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T10:20:42Z","timestamp":1648635642596},"reference-count":55,"publisher":"Japan Society for Clinical Immunology","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn.J.clin.Immun","Jpn. J. Clin. Immunol."],"published-print":{"date-parts":[[2015]]},"DOI":"10.2177\/jsci.38.45","type":"journal-article","created":{"date-parts":[[2015,3,9]],"date-time":"2015-03-09T22:07:52Z","timestamp":1425938872000},"page":"45-56","source":"Crossref","is-referenced-by-count":1,"title":["Management of rheumatoid arthritis medications and pregnancy"],"prefix":"10.2177","volume":"38","author":[{"given":"Yu","family":"FUNAKUBO ASANUMA","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Marunouchi Hospital"},{"name":"Department of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"972","reference":[{"key":"1","unstructured":"1) Nelson, J.L., et al.: Fecundity before disease onset in women with rheumatoid arthritis. Arthritis Rheum<\/i>. 36<\/b>: 7-14, 1993."},{"key":"2","unstructured":"2) Jawaheer, D., et al.: Time to pregnancy among women with rheumatoid arthritis. Arthritis Rheum<\/i>. 63<\/b>: 1517-1521, 2011."},{"key":"3","unstructured":"3) Brouwer, J., et al.: Fertility in women with rheumatoid arthritis: influence of disease activity and medication. Ann Rheum Dis<\/i>. 2014 May 15. pii: annrheumdis-2014-205383. [Epub ahead of Print]"},{"key":"4","unstructured":"4) Boivin, J., et al.: International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care. Hum Reprod<\/i>. 22<\/b>: 1506-1512, 2007."},{"key":"5","unstructured":"5) Juul, S., et al.: Regional differences in waiting time to pregnancy: pregnancy-based surveys from Denmark, France, Germany, Italy and Sweden. The European Infertility and Subfecundity Study Group. Hum Reprod<\/i>. 14<\/b>: 1250-1254, 1999."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Canada, A.L., Schover, L.R.: The psychosocial impact of interrupted childbearing in longterm female cancer survivors. Psychooncology<\/i>. 21<\/b>: 134-143, 2012.","DOI":"10.1002\/pon.1875"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Katz, P.P.: Childbearing decisions and family size among women with rheumatoid arthritis. Arthritis Rheum<\/i>. 55<\/b>: 217-223, 2006.","DOI":"10.1002\/art.21859"},{"key":"8","unstructured":"8) Clowse, M.E., et al.: Effects of infertility, pregnancy loss, and patient concerns on family size of women with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Care & Research<\/i>. 64<\/b>: 668-674, 2012."},{"key":"9","unstructured":"9) Chambers, C.D., et al., The OTIS Collaborative Research Group: Pregnancy outcome in women exposed to leflunomide: The OTIS Autoimmune Diseases in Pregnancy Project. Arthritis Rheum<\/i>. 54<\/b>: S310, 2006."},{"key":"10","unstructured":"10) Bowden, A.P., et al.: Women with inflammatory polyarthritis have babies of lower birth weight. J Rheumatol<\/i>. 28<\/b>: 355-359, 2001."},{"key":"11","unstructured":"11) de Man, Y.A., et al.: Association of higher rheumatoid arthritis disease activity during pregnancy with lower birth weight: results of a national prospective study. Arthritis Rheum<\/i>. 60<\/b>: 3196-3206, 2009."},{"key":"12","unstructured":"12) Norgaard, M., et al.: Rheumatoid arthritis and birth outcomes: a Danish and Swedish nationwide prevalence study. J Intern Med<\/i>. 68<\/b>: 329-337, 2010."},{"key":"13","unstructured":"13) Wallenious, M., et al.: Pregnancy and delivery in women with chronic inflammatory arthritides with a specific focus on first birth. Arthritis Rheum<\/i>. 63<\/b>: 1534-1542, 2011."},{"key":"14","unstructured":"14) de Man, Y.A., et al.: Disease activity of rheumatoid arthritis during pregnancy: results from a nationwide prospective study. Arthritis Care & Research<\/i>. 59<\/b>: 1241-1248, 2008."},{"key":"15","unstructured":"15) \u00d8stensen, M., et al.: A prospective study of pregnant patients with rheumatoid arthritis and ankylosing spondylitis using validated clinical instruments. Ann Rheum Dis<\/i>. 63<\/b>: 1212-1217, 2004."},{"key":"16","unstructured":"16) F\u00f6rger, F., et al.: Pregnancy mediated improvement of rheumatoid arthritis. Swiss Med Wkly<\/i>. 142<\/b>: w13644, 2012."},{"key":"17","unstructured":"17) de Man, Y.A., et al.: Women with rheumatoid arthritis negative for anticyclic citrullinated peptide and rheumatoid factor are more likely to improve during pregnancy, whereas in autoantobody-positive women autoantibody levels are not influenced by pregnancy. Ann Rheum Dis<\/i>. 69<\/b>: 420-423, 2010."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Nelson, J.L., Ostensen, M.: Pregnancy and rheumatoid arthritis. Rheum Dis Clin North Am<\/i>. 23<\/b>: 195-212, 1997.","DOI":"10.1016\/S0889-857X(05)70323-9"},{"key":"19","unstructured":"19) de Man, Y., et al.: Measuring disease activity and functionality during pregnancy in patients with rheumatoid arthritis. Arthritis Rheum<\/i>. 57<\/b>: 716-722, 2007."},{"key":"20","unstructured":"20) Russell, A.S., et al.: Evidence for reduced Thl function in normal pregnancy: A hypothesis for the remission of rheumatoid arthritis. J Rheumatol<\/i>. 24<\/b>: 1045-1050, 1997."},{"key":"21","unstructured":"21) Forger, F., et al.: Pregnancy induces numerical and functional changes of CD4+CD25+ high regulatory T cells in patients with rheumatoid arthritis. Ann Rheum Dis<\/i>. 67<\/b>: 984-990, 2008."},{"key":"22","unstructured":"22) Somerset, D.A., et al.: Normal human pregnancy is associated with an elevation in the immune suppressive CD25+CD4+ regulatory T-cell subset. Immunology<\/i>. 112<\/b>: 38-43, 2004."},{"key":"23","unstructured":"23) \u00d8stensen, M., et al.: Pregnancy in patients with rheumatic disease: anti-inflammatory cytokines increase in pregnancy and decrease post partum. Ann Rheum Dis<\/i>. 64<\/b>: 839-844, 2005."},{"key":"24","unstructured":"24) Li, D.K., et al.: Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study. Br Med J<\/i>. 327<\/b>: 368-373, 2003."},{"key":"25","unstructured":"25) Schoenfeld, A., et al.: NSAIDs: metarnal and fetal considerations. Am J Reprod Immunol<\/i>. 28<\/b>: 141-147, 1992."},{"key":"26","unstructured":"26) Daniel, S., et al.: Major malformations following exposure to nonsteroidal antiinflammatory drugs during the first trimester of pregnancy. J Rheumatol<\/i>. 39<\/b>: 2163-2169, 2012."},{"key":"27","unstructured":"27) Park-Wyllie, L., et al.: Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology<\/i>. 62<\/b>: 385-392, 2000."},{"key":"28","unstructured":"28) \u00d8stensen, M., et al.: Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther<\/i>. 8<\/b>: 209, 2006."},{"key":"29","unstructured":"29) Weber-Schoendorfer, C., et al.: Pregnancy outcome after methotrexate treatment for rheumatic disease prior to or during early pregnancy: a prospective multicenter cohort study. Arthritis Rheumatol<\/i>. 66<\/b>: 1101-1110, 2014."},{"key":"30","unstructured":"30) Weber-Schoendorfer, C., et al.: No evidence for an increased risk of adverse pregnancy outcome after paternal low-dose methotreate: an observational cohort study. Rheumatology<\/i>. 53<\/b>: 757-763, 2014."},{"key":"31","unstructured":"31) Jarnerot, G., et al.: Placental transfer of sulfasalazine and sulfapyridine and some of its metabolites. Scand J Gastroenterol<\/i>. 16<\/b>: 693-697, 1981."},{"key":"32","unstructured":"32) Chatzinoff, M., et al.: Sulfasalazine-induced abnormal sperm penereation assay reversed on changing to 5-aminosalicylic acid enemas. Dig Dis Sci<\/i>. 33<\/b>: 108-110, 1988."},{"key":"33","unstructured":"33) Nevers, W., et al.: Safety of tacrolimus in pregnancy. Can Fam Physician<\/i>. 60<\/b>: 905-906, 2014."},{"key":"34","unstructured":"34) Cush, J.J.: Biological drug use: US perspectives on indications and monitoring. Ann Rheum Dis<\/i>. 64<\/b>: iv18-iv23, 2005."},{"key":"35","unstructured":"35) Carter, J.D., et al.: A safety assessment of tumor necrosis factor antagonists during pregnancy: a review of the Food and Drug Administration databese. J Rheumatol<\/i>. 36<\/b>: 635-664, 2009."},{"key":"36","unstructured":"36) Crijns, H.J., et al.: The distribution of congenital anomalies within the VACTERL association among tumor nectrosis factor antagonist-exposed pregnancies is similar to the general population. J Rheumatol<\/i>. 38<\/b>: 1871-1874, 2011."},{"key":"37","unstructured":"37) Mahadevan, U., et al.: Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease. Clin Gastroenterol Hepatol<\/i>. 11<\/b>: 286-292, 2013."},{"key":"38","unstructured":"38) Cheent, K., et al.: Case Report: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's disease. J Crohns Colitis<\/i>. 4<\/b>: 603-605, 2010."},{"key":"39","unstructured":"39) Mahadevan, U., et al.: The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: pregnancy and Pediatrics. Am J Gastroenterol<\/i>. 106<\/b>: 214-223, 2011."},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Sammaritano, L.R., Bermas, B.L.: Rheumatoid arthritis medications and lactation. Curr Opin Rheumatol<\/i>. 26<\/b>: 354-360, 2014.","DOI":"10.1097\/BOR.0000000000000055"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Hyrich, K.L., Verstappen, S.M.M.: Biologic therapies and pregnancy: the story so far. Rheumatology<\/i>. 53<\/b>: 1377-1385, 2014.","DOI":"10.1093\/rheumatology\/ket409"},{"key":"42","unstructured":"42) Murashima, A., et al.: Etanercept during pregnancy and lactation in a patient with rheumatoid arthritis: drug levels in maternal serum, cord blood, breast milk and the infant's serum. Ann Rheum Dis<\/i>. 68<\/b>: 1793-1794, 2009."},{"key":"43","unstructured":"43) Ben-Horin, S., et al.: Adalimumab level in breast milk of a nursing mother. Clin Gastroenterol hepatol<\/i>. 8<\/b>: 475-476, 2010."},{"key":"44","unstructured":"44) Stephens, P., et al.: Placental transfer of he anti-TNF antibody TN3 in rats: comparison of immunoglobulin G1 and pegylated Fab versions. Gut<\/i>. 5<\/b>: A8, 2006."},{"key":"45","unstructured":"45) \u00d8stensen, M., et al.: Therapy with immunosuppressive drugs and biological agents and use of contraception in patients with rheumatic disease. J Rheumatol<\/i>. 34<\/b>: 1266-1269, 2007."},{"key":"46","unstructured":"46) Hazes, J.M., et al.: Rheumatoid arthritis and pregnancy: evolution of disease activity and pathophysiological considerations for drug use. Rheumatology<\/i>. 50<\/b>: 1955-1968, 2011."},{"key":"47","unstructured":"47) Kozlowski, R.D., et al.: Outcome of first-trimester exposure to low-dose methotrexate in eight patients with rheumatic disease. Am J Med<\/i>. 88<\/b>: 589-592, 1990."},{"key":"48","unstructured":"48) \u00d8stensen, M., et al.: Low dose weekly methotrexate in early pregnancy. A case series and review of the literature. J Rheumatol<\/i>. 27<\/b>: 1872-1875, 2000."},{"key":"49","unstructured":"49) Chakravarty, E.F., et al.: The use of disease modifying antirheumatic drugs in women with rheumatoid arthritis of childbearing age: a survey of practice patterns and pregnancy outcomes. J Rheumatol<\/i>. 30<\/b>: 241-246, 2003."},{"key":"50","unstructured":"50) Lewden, B., et al.: Low dose methotrexate in the first trimester of pregnancy:results of a French collaborative study. J Rheumatol<\/i>. 31<\/b>: 2360-2365, 2004."},{"key":"51","unstructured":"51) Hoyert, D.L., et al.: Annual summary of vital statistics: 2004. Pediatrics<\/i>. 117<\/b>: 168-183, 2006."},{"key":"52","doi-asserted-by":"crossref","unstructured":"52) \u00d8stensen, M.: Safety issues of biologics in pregnant patients with rheumatic diseases. Ann N Y Acad Sci<\/i>. 1317<\/b>: 32-38, 2014.","DOI":"10.1111\/nyas.12456"},{"key":"53","unstructured":"53) Clowse, M.E.B., et al.: Retrospective analysis of certolizumab pegol use during pregnancy: update of impact on birth outcomes. Arthritis Rheum<\/i>. 65<\/b>: 2013."},{"key":"54","unstructured":"54) Robbert-Roth, A., et al.: First experiences with pregnancies in RA patients receiving Tocilizumab therapy. Arthritis Rheum<\/i>. 62<\/b>: S161, 2010."},{"key":"55","unstructured":"55) Bramham, K., et al.: Breastfeeding and tacrolimus: serial monitoring in breast-fed and bottle-fed infants. Clin J Am Soc Nephrol<\/i>. 8<\/b>: 563-567, 2013."}],"container-title":["Japanese Journal of Clinical Immunology"],"original-title":["\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u306e\u6cbb\u7642\u3068\u598a\u5a20\u306e\u4e21\u7acb"],"language":"en","deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T06:58:55Z","timestamp":1498201135000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsci\/38\/1\/38_45\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.2177\/jsci.38.45","relation":{},"ISSN":["0911-4300","1349-7413"],"issn-type":[{"value":"0911-4300","type":"print"},{"value":"1349-7413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}